Table 1.
Clinico-pathological details of 101 patients receiving radical cystectomy evaluable on TMA for T cell and TME-panel with multiplex immunohistochemistry.
| n = 101 | ||
|---|---|---|
| Median age (IQR) | 68 (59–75) | |
| Gender | ||
| Male | 78 (77%) | |
| Female | 23 (23%) | |
| Max. tumor-stage | ||
| pT2 | 24 (24%) | |
| pT3 | 57 (56%) | |
| pT4 | 20 (20%) | |
| Lymph node status | ||
| pN0 | 49 (49%) | |
| pN+/pNx | 52 (51%) | |
| Histological subtype | ||
| NOS | 73 (72%) | |
| Squamous | 11 (11%) | |
| Micropapillary | 6 (6%) | |
| Neuroendocine | 3 (3%) | |
| Sarcomatoid | 2 (2%) | |
| Plasmacytoid | 2 (2%) | |
| Other (2 Lymphoepithelial, 1 Glandular, 1 Giant cell) | 4 (4%) | |
| Min. 2 cycles adjuvant chemotherapy | ||
| No | 67 (66%) | |
| Yes | 34 (34%) | |
IQR interquartile range, NOS not otherwise specified